Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for ESCITALOPRAM

Ingredient

ESCITALOPRAM

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ESCITALOPRAM	20MG	TABLET	Resolved	2023-01-12	2023-04-28	180906
TEVA-ESCITALOPRAM	10MG	TABLET	Resolved	2023-06-16	2023-06-27	195133
TEVA-ESCITALOPRAM	10MG	TABLET	Resolved	2023-06-08	2023-06-27	194141
TEVA-ESCITALOPRAM	10MG	TABLET	Resolved	2022-09-30	2022-12-02	170798
TEVA-ESCITALOPRAM	10MG	TABLET	Resolved	2020-07-09	2021-02-05	119877

Previous
1
…
13
14
15

Showing 141 to 145 of 145

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
PMSC-ESCITALOPRAM	20MG	TABLET	Discontinued	2020-06-15	2021-10-27	117879
M-ESCITALOPRAM	10MG	TABLET	Discontinued	2020-03-18	2020-03-18	108917
NAT-ESCITALOPRAM	10MG	TABLET	Discontinued	2026-01-06	2026-01-06	275276
NAT-ESCITALOPRAM	20MG	TABLET	Discontinued	2026-01-06	2026-01-06	275279

Showing 11 to 14 of 14